Home Healthcare Pharmaceuticals Parkinson's Disease Drugs Market

Parkinson's Disease Drugs Market Size, Share & Trends Analysis Report By Mechanism of Action (Dopamine Agonists, Anticholinergic, MAO-B inhibitors, Amantadine, Carbidopa-levodopa, COMT Inhibitors, Other Mechanisms of Action) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: May 25, 2026 | Author: Debashree B | Format: | Report Code: SR3530DR | Pages: 156
Overview TOC Segmentation Methodology
Download Free Sample

Table Of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Parkinson's Disease Drugs Market Size Analysis
    1. Introduction
    2. Parkinson's Disease Drugs Market Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
      1. Dopamine Agonists
      2. Anticholinergic
      3. MAO-B inhibitors
      4. Amantadine
      5. Carbidopa-levodopa
      6. COMT Inhibitors
      7. Other Mechanisms of Action 
  7. North America Parkinson's Disease Drugs Market Size Analysis
    1. Introduction
    2. Parkinson's Disease Drugs Market Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
      1. Dopamine Agonists
      2. Anticholinergic
      3. MAO-B inhibitors
      4. Amantadine
      5. Carbidopa-levodopa
      6. COMT Inhibitors
      7. Other Mechanisms of Action 
    3. U.S.
      1. Introduction
      2. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Dopamine Agonists
        2. Anticholinergic
        3. MAO-B inhibitors
        4. Amantadine
        5. Carbidopa-levodopa
        6. COMT Inhibitors
        7. Other Mechanisms of Action 
    4. Canada
      1. Introduction
      2. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Dopamine Agonists
        2. Anticholinergic
        3. MAO-B inhibitors
        4. Amantadine
        5. Carbidopa-levodopa
        6. COMT Inhibitors
        7. Other Mechanisms of Action 
  8. Europe Parkinson's Disease Drugs Market Size Analysis
    1. Introduction
    2. Parkinson's Disease Drugs Market Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
      1. Dopamine Agonists
      2. Anticholinergic
      3. MAO-B inhibitors
      4. Amantadine
      5. Carbidopa-levodopa
      6. COMT Inhibitors
      7. Other Mechanisms of Action 
    3. U.K.
      1. Introduction
      2. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Dopamine Agonists
        2. Anticholinergic
        3. MAO-B inhibitors
        4. Amantadine
        5. Carbidopa-levodopa
        6. COMT Inhibitors
        7. Other Mechanisms of Action 
    4. Germany
      1. Introduction
      2. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Dopamine Agonists
        2. Anticholinergic
        3. MAO-B inhibitors
        4. Amantadine
        5. Carbidopa-levodopa
        6. COMT Inhibitors
        7. Other Mechanisms of Action 
    5. France
      1. Introduction
      2. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Dopamine Agonists
        2. Anticholinergic
        3. MAO-B inhibitors
        4. Amantadine
        5. Carbidopa-levodopa
        6. COMT Inhibitors
        7. Other Mechanisms of Action 
    6. Spain
      1. Introduction
      2. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Dopamine Agonists
        2. Anticholinergic
        3. MAO-B inhibitors
        4. Amantadine
        5. Carbidopa-levodopa
        6. COMT Inhibitors
        7. Other Mechanisms of Action 
    7. Italy
      1. Introduction
      2. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Dopamine Agonists
        2. Anticholinergic
        3. MAO-B inhibitors
        4. Amantadine
        5. Carbidopa-levodopa
        6. COMT Inhibitors
        7. Other Mechanisms of Action 
    8. Russia
      1. Introduction
      2. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Dopamine Agonists
        2. Anticholinergic
        3. MAO-B inhibitors
        4. Amantadine
        5. Carbidopa-levodopa
        6. COMT Inhibitors
        7. Other Mechanisms of Action 
    9. Nordic
      1. Introduction
      2. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Dopamine Agonists
        2. Anticholinergic
        3. MAO-B inhibitors
        4. Amantadine
        5. Carbidopa-levodopa
        6. COMT Inhibitors
        7. Other Mechanisms of Action 
    10. Benelux
      1. Introduction
      2. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Dopamine Agonists
        2. Anticholinergic
        3. MAO-B inhibitors
        4. Amantadine
        5. Carbidopa-levodopa
        6. COMT Inhibitors
        7. Other Mechanisms of Action 
    11. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Dopamine Agonists
        2. Anticholinergic
        3. MAO-B inhibitors
        4. Amantadine
        5. Carbidopa-levodopa
        6. COMT Inhibitors
        7. Other Mechanisms of Action 
  9. APAC Parkinson's Disease Drugs Market Size Analysis
    1. Introduction
    2. Parkinson's Disease Drugs Market Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
      1. Dopamine Agonists
      2. Anticholinergic
      3. MAO-B inhibitors
      4. Amantadine
      5. Carbidopa-levodopa
      6. COMT Inhibitors
      7. Other Mechanisms of Action 
    3. China
      1. Introduction
      2. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Dopamine Agonists
        2. Anticholinergic
        3. MAO-B inhibitors
        4. Amantadine
        5. Carbidopa-levodopa
        6. COMT Inhibitors
        7. Other Mechanisms of Action 
    4. Korea
      1. Introduction
      2. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Dopamine Agonists
        2. Anticholinergic
        3. MAO-B inhibitors
        4. Amantadine
        5. Carbidopa-levodopa
        6. COMT Inhibitors
        7. Other Mechanisms of Action 
    5. Japan
      1. Introduction
      2. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Dopamine Agonists
        2. Anticholinergic
        3. MAO-B inhibitors
        4. Amantadine
        5. Carbidopa-levodopa
        6. COMT Inhibitors
        7. Other Mechanisms of Action 
    6. India
      1. Introduction
      2. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Dopamine Agonists
        2. Anticholinergic
        3. MAO-B inhibitors
        4. Amantadine
        5. Carbidopa-levodopa
        6. COMT Inhibitors
        7. Other Mechanisms of Action 
    7. Australia
      1. Introduction
      2. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Dopamine Agonists
        2. Anticholinergic
        3. MAO-B inhibitors
        4. Amantadine
        5. Carbidopa-levodopa
        6. COMT Inhibitors
        7. Other Mechanisms of Action 
    8. Singapore
      1. Introduction
      2. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Dopamine Agonists
        2. Anticholinergic
        3. MAO-B inhibitors
        4. Amantadine
        5. Carbidopa-levodopa
        6. COMT Inhibitors
        7. Other Mechanisms of Action 
    9. Taiwan
      1. Introduction
      2. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Dopamine Agonists
        2. Anticholinergic
        3. MAO-B inhibitors
        4. Amantadine
        5. Carbidopa-levodopa
        6. COMT Inhibitors
        7. Other Mechanisms of Action 
    10. South East Asia
      1. Introduction
      2. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Dopamine Agonists
        2. Anticholinergic
        3. MAO-B inhibitors
        4. Amantadine
        5. Carbidopa-levodopa
        6. COMT Inhibitors
        7. Other Mechanisms of Action 
    11. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Dopamine Agonists
        2. Anticholinergic
        3. MAO-B inhibitors
        4. Amantadine
        5. Carbidopa-levodopa
        6. COMT Inhibitors
        7. Other Mechanisms of Action 
  10. Middle East and Africa Parkinson's Disease Drugs Market Size Analysis
    1. Introduction
    2. Parkinson's Disease Drugs Market Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
      1. Dopamine Agonists
      2. Anticholinergic
      3. MAO-B inhibitors
      4. Amantadine
      5. Carbidopa-levodopa
      6. COMT Inhibitors
      7. Other Mechanisms of Action 
    3. UAE
      1. Introduction
      2. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Dopamine Agonists
        2. Anticholinergic
        3. MAO-B inhibitors
        4. Amantadine
        5. Carbidopa-levodopa
        6. COMT Inhibitors
        7. Other Mechanisms of Action 
    4. Turkey
      1. Introduction
      2. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Dopamine Agonists
        2. Anticholinergic
        3. MAO-B inhibitors
        4. Amantadine
        5. Carbidopa-levodopa
        6. COMT Inhibitors
        7. Other Mechanisms of Action 
    5. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Dopamine Agonists
        2. Anticholinergic
        3. MAO-B inhibitors
        4. Amantadine
        5. Carbidopa-levodopa
        6. COMT Inhibitors
        7. Other Mechanisms of Action 
    6. South Africa
      1. Introduction
      2. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Dopamine Agonists
        2. Anticholinergic
        3. MAO-B inhibitors
        4. Amantadine
        5. Carbidopa-levodopa
        6. COMT Inhibitors
        7. Other Mechanisms of Action 
    7. Egypt
      1. Introduction
      2. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Dopamine Agonists
        2. Anticholinergic
        3. MAO-B inhibitors
        4. Amantadine
        5. Carbidopa-levodopa
        6. COMT Inhibitors
        7. Other Mechanisms of Action 
    8. Nigeria
      1. Introduction
      2. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Dopamine Agonists
        2. Anticholinergic
        3. MAO-B inhibitors
        4. Amantadine
        5. Carbidopa-levodopa
        6. COMT Inhibitors
        7. Other Mechanisms of Action 
    9. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Dopamine Agonists
        2. Anticholinergic
        3. MAO-B inhibitors
        4. Amantadine
        5. Carbidopa-levodopa
        6. COMT Inhibitors
        7. Other Mechanisms of Action 
  11. LATAM Parkinson's Disease Drugs Market Size Analysis
    1. Introduction
    2. Parkinson's Disease Drugs Market Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
      1. Dopamine Agonists
      2. Anticholinergic
      3. MAO-B inhibitors
      4. Amantadine
      5. Carbidopa-levodopa
      6. COMT Inhibitors
      7. Other Mechanisms of Action 
    3. Brazil
      1. Introduction
      2. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Dopamine Agonists
        2. Anticholinergic
        3. MAO-B inhibitors
        4. Amantadine
        5. Carbidopa-levodopa
        6. COMT Inhibitors
        7. Other Mechanisms of Action 
    4. Mexico
      1. Introduction
      2. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Dopamine Agonists
        2. Anticholinergic
        3. MAO-B inhibitors
        4. Amantadine
        5. Carbidopa-levodopa
        6. COMT Inhibitors
        7. Other Mechanisms of Action 
    5. Argentina
      1. Introduction
      2. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Dopamine Agonists
        2. Anticholinergic
        3. MAO-B inhibitors
        4. Amantadine
        5. Carbidopa-levodopa
        6. COMT Inhibitors
        7. Other Mechanisms of Action 
    6. Chile
      1. Introduction
      2. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Dopamine Agonists
        2. Anticholinergic
        3. MAO-B inhibitors
        4. Amantadine
        5. Carbidopa-levodopa
        6. COMT Inhibitors
        7. Other Mechanisms of Action 
    7. Colombia
      1. Introduction
      2. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Dopamine Agonists
        2. Anticholinergic
        3. MAO-B inhibitors
        4. Amantadine
        5. Carbidopa-levodopa
        6. COMT Inhibitors
        7. Other Mechanisms of Action 
    8. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Mechanism of Action 2022-2034 (USD MILLION/ Units)
        1. Dopamine Agonists
        2. Anticholinergic
        3. MAO-B inhibitors
        4. Amantadine
        5. Carbidopa-levodopa
        6. COMT Inhibitors
        7. Other Mechanisms of Action 
  12. Competitive Landscape
    1. Parkinson's Disease Drugs Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. AbbVie Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Orion Corporation
    3. Amneal Pharmaceuticals Inc.
    4. Boehringer Ingelheim GmbH
    5. Supernus Pharmaceuticals Inc.
    6. GlaxoSmithKline PLC
    7. Teva Pharmaceutical Industries Ltd
    8. Pfizer Inc.
    9. F Hoffmann-La Roche AG
    10. Takeda Pharmaceutical Company Ltd.
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  16. Disclaimer
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.